Divya Pharmacy

5 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED3 refused lines

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• LACKS N/C1 refused line

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

Questions about Divya Pharmacy

Is Divya Pharmacy on an FDA import alert?

No listing for Divya Pharmacy appears in the FDA import alerts SupplierRadar checked on October 25, 2026. Country-wide alerts may still apply to its products; see the India page.

Has FDA refused shipments from Divya Pharmacy?

Yes. FDA refused 4 shipment lines from Divya Pharmacy between April 22, 2025 and August 6, 2026. The most recent, on August 6, 2026, was ashwagandha (herbal & botanicals, not teas), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Divya Pharmacy's shipments?

The most frequent charges are UNAPPROVED (unapproved new drug, 3 lines) and LACKS N/C (net quantity statement missing, 1 line).

When was Divya Pharmacy last inspected by FDA?

FDA's most recent inspection of Divya Pharmacy with a final classification is dated July 1, 2016 and was classified VAI (Voluntary Action Indicated).

What is Divya Pharmacy's FEI number?

Divya Pharmacy's FDA Establishment Identifier (FEI) is 3007846706.